Validation of the Critical-Care Pain Observation Tool (CPOT) in the Greek Population
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03654443 |
|
Recruitment Status :
Suspended
(The study is currently suspended due to the COVID19 crisis)
First Posted : August 31, 2018
Last Update Posted : March 31, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pain Intensive Care Units | Diagnostic Test: Critical care pain observation tool | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 74 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Masking Description: | Only the two observers are aware of the study group and none of the rest of the study team |
| Primary Purpose: | Other |
| Official Title: | Greek Validation of the Critical-Care Pain Observation Tool (CPOT) in the Intensive Care Unit Setting |
| Actual Study Start Date : | July 1, 2018 |
| Estimated Primary Completion Date : | October 1, 2020 |
| Estimated Study Completion Date : | January 1, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Group Painful stimulus
The CPOT tool is administered in a crossover manner in Group one prior to a painful stimulus (IT0), during the painful stimulus (IT1) and soon afterwards (IT2)
|
Diagnostic Test: Critical care pain observation tool
The CPOT tool is administered in a crossover manner by two study observers |
|
Experimental: Group Non-painful stimulus
The CPOT tool is administered in a crossover manner in Group one prior to a non-painful stimulus (IIT0), during the painful stimulus (IIT1) and soon afterwards (IIT2)
|
Diagnostic Test: Critical care pain observation tool
The CPOT tool is administered in a crossover manner by two study observers |
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool) is administered 1 minute prior to a painful stimulus (ITime0) which is set to be the patient's bed repositioning ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool(Critical Care Pain Observation Tool) is administered 10 seconds after a painful stimulus (ITime1) which is set to be the patient's bed repositioning ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool(Critical Care Pain Observation Tool) is administered 1 minute after a painful stimulus (ITime2) which is set to be the patient's bed repositioning ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool)is administered 20 minutes after a painful stimulus (ITime3) which is set to be the patient's bed repositioning ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool)is administered 1 minute prior to a non painful stimulus (IITime0) which is set to be the patient's blood pressure measurement ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool(Critical Care Pain Observation Tool) is administered 10 seconds after a non painful stimulus (IITime1) which is set to be the patient's blood pressure measurement ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool)is administered 1 minute after a painful stimulus (IITime2) which is set to be the patient's blood pressure measurement ]Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.
- Correlation of physiological parameters to CPOT tool (Critical Care Pain Observation Tool) values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]Physiological parameters as mean arterial blood pressure (MAP in mmHg) will be recorded in all patients. In order to calculate the mean arterial pressure, systolic and diastolic pressures will be recorded in the time periods of the assessment.
- Correlation of numeric pain rating scale (NPRS) to CPOT tool (Critical Care Pain Observation Tool)values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]NPRS scale (0 equals no pain and 10 equals maximum pain possible)will be performed in all patients that are able to communicate in order to correlate the results with those of the CPOT tool
- Correlation of physiological parameters to CPOT tool(Critical Care Pain Observation Tool) values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]Physiological parameters as heart rate will be recorded in all patients.
- Correlation of physiological parameters to CPOT tool (Critical Care Pain Observation Tool)values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]Physiological parameters as respiratory rate will be recorded in all patients
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients admitted in the ICU
- Age> 18 years old
- No hearing or visual deficit
- No contraindication to body repositioning
Exclusion Criteria:
- Patients with neurological deficit
- Patients administered with neuromuscular blocking agents
- Patients with motor or sensory deficits
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03654443
| Greece | |
| Saint Savvas Anticancer Hospital of Athens | |
| Athens, Greece | |
| Principal Investigator: | Georgia Micha, MD, MSc, PhD | Saint Savvas Anticancer Hospital of Athens |
| Responsible Party: | Georgia Micha, Principal Investigator, Anaesthesiologist, MD, MSc, PhD, Saint Savvas Anticancer Hospital |
| ClinicalTrials.gov Identifier: | NCT03654443 |
| Other Study ID Numbers: |
StSavvasAH |
| First Posted: | August 31, 2018 Key Record Dates |
| Last Update Posted: | March 31, 2020 |
| Last Verified: | March 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pain Neurologic Manifestations |

